References
Abudawood, M., Tabassum, H. & Atheer, H. (2021). Antioxidants status in relation to heavy metals induced oxidative stress in patients with polycystic ovarian syndrome. Scientific Reports, 11(1),22935. https://doi.org/10.1038/s41598-021-02120-6
Abuja, P. M. & Albertini, R. (2001). Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clinica Chimica Acta; International Journal of Clinical Chemistry, 306(1–2), 1–17. https://doi.org/10.1016/s0009-8981(01)00393-x.
Agarwal, A., Gupta, S. & Sharma, R. K. (2005). Role of oxidative stress in female reproduction. Reproductive Biology and Endocrinology: RB&E, 3(1), 28. https://doi.org/10.1186/1477-7827-3-28.
Allen, R. G. & Tresini, M. (2000). Oxidative stress and gene regulation. Free Radical Biology & Medicine, 28(3), 463–499. https://doi.org/10.1016/s0891-5849(99)00242-7
Alahmar AT & Sengupta P. (2021) Impact of coenzyme Q10 and selenium on seminal fluid parameters and antioxidant status in men with idiopathic infertility. Biol Trace Elem Res. ;199(4), 1246–52. https://doi.org/10.1007/s12011-020-02251-3
Behrman, H. R., Kodaman, P. H., Preston, S. L., & Gao, S. (2001). Oxidative stress and the ovary. Journal of the Society for Gynecologic Investigation, 8(1_suppl), S40–S42. https://doi.org/10.1177/1071557601008001s13.
Bellver, J., Melo, M. A., Bosch, E., Sewa, V., Remotin, J., & Pellier, A. (2007). Obesity and poor reproductive outcome; the potential role of the endometrium. Fertil Steril, 88(2), 446–451. https://doi.org/10.1016/j.fertnstert.2 006.11.162
Blair, S. A., Kyaw-Tun, T., Young, I. S., Phelan, N. A., Gibney, J., & McEneny, J. (2013). Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome. The Journal of Reproductive Medicine, 58(3–4), 107–114. PMID: 23539878.
Coskun, A., Arikan, T., Kilinc, M., & Cekerbicer, A. D. (2013). Plasma selenium levels in Turkish women with polycystic ovary syndrome . Eur.J.Obstet.Gynecol.Reprod.Biol, 168. https://doi.org/10.1016/j.ejogrb.2013.01.021
Darbandi M, Darbandi S, Agarwal A, Sengupta P, Durairajanayagam D, Henkel R, et al. (2018) Reactive oxygen species and male reproductive hormones. Reprod Biol Endocrinol., 16(1),87. https://doi.org/10.1186/s12958-018-0406-2
Dinger, Y., Akcay, T., Erdem, T., Saygili, I., & Gundogdu, E. (2005). DNA damage DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome. Scand J Clin Lab Invest, 65(8), 721–728. https://doi.org/10.1080/00365510500375263
Dumesic, D. A., Meldrum, D. R., Katz-Jaffe, M. G., Krisher, R. L. & Schoolcraft, W. B. (2015). Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertility and Sterility, 103(2), 303–316. https://doi.org/10.1016/j.fertnstert.2014.11.015.
Fan, P., Liu, H., Wang, Y., Zhang, F. & Bai, H. (2012). Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS. Reproductive Biomedicine Online, 24(2), 197–205. https://doi.org/10.1016/j.rbmo.2011.10.010.
Fatim, Q., Amim, S., Kawa, I. A., Jeelani, H., Manzoor, S., Rizvi, S. M. & Rashid, F. (2019). Evaluation of antioxidants defense markers in relation to hormonal and insulinparameters in women with polycystic ovary syndrome (PCOS): A case-control study. Diab Metab. Syndr, 13, 1957–1961. https://doi.org/10.1016/j.dsx.2019.04.032
Forman, H. J. & Zhang, H. (2021). Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov , 20(9), 689–709. https://doi.org/10.1038/s41573-021-00233-1
Gurdol, F., Cimşit, M., Oner-Iyidoğan, Y., Körpinar, S., Yalçinkaya, S. & Koçak, H. (2008). Early and late effects of hyperbaric oxygen treatment on oxidative stress parameters in diabetic patients. Physiological Research, 57(1), 41–47. https://doi.org/10.33549/physiolres.931139.
Hassan, R. J. & Al-Husseini, A. M. H. (Eds.). (2019). Estimation of catalase activity and Malondialdehyde levels in blood groups ABO of PCOS patients”. In Journal of Physics: Conf. Series. http://doi.org/10.1088/1742-6596/1294/6/062100
Herman, R., Jensterle Sever, M., Janez, A. & Dolzan, V. (2020). Interplay between oxidative stress and chronic inflammation in PCOS: The role of genetic variability in PCOS risk and treatment responses. In Polycystic Ovarian Syndrome. IntechOpen.
Joo Yeon Lee, C.-K., Baw, S., Gupta, N. & Aziz, A. (2010). Role of Oxidative stress in Polycystic ovary syndrome, Current Women’s Health Reviews, 6, 96–107. http://dx.doi.org/10.2174/157340410791321336
Kaltsas, A., Zikopoulos, A., Moustakli, E., Zachariou, A., Tsirka, G., Tsiampali, C., Palapela, N., Sofikitis, N. & Dimitriadis, F. (2023). The silent threat to women’s fertility: Uncovering the devastating effects of oxidative stress. Antioxidants (Basel, Switzerland), 12(8). https://doi.org/10.3390/antiox12081490.
Konar, H. (2020). DC Dutta’s textbook of gynaecology (8th ed.). Jaypee Brothers Medical.
Kuscu, N. K. & Var, A. (2009). Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica, 88(5), 612–617. https://doi.org/10.1080/00016340902859315.
Li, W., Liu, C., Yang, Q. Zhou, Y., Liu, M. & Shan, H. (2022). Oxidative stress and antioxidant inbalance in ovulation disorder in patients with polycystic ovary syndrome. Sec. Nutri and Metab. https://doi.org/10.3389%2Ffnut.2022.1018674
Macut, D., Simic, T., Lissounov, A., Pljesa-Ercegovac, M., Bozic, I., Djukic, T., Bjekic-Macut, J., Matic, M., Petakov, M., Suvakov, S., Damjanovic, S. & Savic-Radojevic, A. (2011). Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. Experimental and Clinical Endocrinology & Diabetes, 119(7), 451–455. https://doi.org/10.1055/s-0031-1279740.
Maha, A. H., Yahya, M., Maha, M., Ai-Khaduri, J. & Mostafa, I. (2018). Polycystic ovarian syndrome is linked to increased oxidative stress in Omani women. Int J Women’s Health, 10–763. https://doi.org/10.1096/fasebj.2018.32.1_supplement.787.11
Merendino, R. A., Salvo, F., Saija, A., Di Pasquale, G., Tomaino, A., Minciullo, P. L., Fraccica, G. & Gangemi, S. (2003). Malondialdehyde in benign prostate hypertrophy: a useful marker? Mediators of Inflammation, 12(2), 127–128. https://doi.org/10.1080/0962935031000097745.
Miyamoto, K., Sato, E. F., Kasahara, E., Jikumaru, M., Hiramoto, K., Tabata, H., Katsuragi, M., Odo, S., Utsumi, K. & Inoue, M. (2010). Effect of oxidative stress during repeated ovulation on the structure and functions of the ovary, oocytes, and their mitochondria. Free Radical Biology & Medicine, 49(4), 674–681. https://doi.org/10.1016/j.freeradbiomed.2010.05.025.
Mortada, R. & Williams, T. (2015). Metabolic syndrome: Polycystic ovary syndrome. FP Essentials, 435, 30–42.
Murri, M., Luque-Ramirez, M., Insenser, M., Ojeda-Ojeda, M. & Escobar-Morreale, H. F. (2013). Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS):a systematic review and meta-analysis. Human Reproduction Update, 19(3), 268–288. https://doi.org/10.1093/humupd/dms059
Sabuncu, T., Vural, H., Harma, M. & Harma, M. (2001). Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clinical Biochemistry, 34(5), 407–413. https://doi.org/10.1016/s0009-9120(01)00245-4.
Seleem, A. K., El Refaeey, A. A., Shaalan, D., Sherbiny, Y. & Badawy, A. (2014). Superoxide dismutase in polycstic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assist Reprod Genet, 31, 499–504. https://doi.org/10.1007/s10815-014-0190-7
Sengupta P, Dutta S. & Hassa MF. (2024) Polycystic ovary syndrome (PCOS) and oxidative stress. Integr Sci Technol. ;12(3):752. https://doi.org/10.62110/sciencein.jist.2024.v12.752
Senoner, T. & Dichtl, W. (2019). Oxidative stress in cardiovascular diseases: Still a therapeutic target? Nutrients, 11(9), 2090. https://doi.org/10.3390/nu11092090
Shkolnik, K., Tadmor, A., Ben-Dor, S., Nevo, N., Galiani, D., & Dekel, N. (2011). Reactive oxygen species are indispensable in ovulation. Procedings of the National Academy of Sciences of the United States of America, 108(4), 1462–1467. https://doi.org/10.1073/pnas.1017213108
Skrgatic, L., Baldami, D. P. & Cerne, J. (2012). P&Gersak, K CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influence serum testosterone levels. J Steriod Biochem.Mol.Biol, 128. https://doi.org/10.1016/j.jsbmb.20 11.11.006
Talat, A., Satyanarayana, P. & Anand, P. (2022). Association of superoxide dismutase level in women with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology of India, 72(1), 6–12. https://doi.org/10.1007/s13224-021-01430-z.
Turan, E. D., V., Sezer, B. & Zeybek, F. (2015). Infertility and the presence of insulin resistance are associated with increased oxidative stress in young ,non-obese Turkish women with polycystic ovary syndrome. J Pediat and Adolescent Gynec, 28(2), 119–123. https://doi.org/10.1016/j.jpag.2014.05.003
Uckan, K., Demir, H., Turan, K., Sarikaya, E. & Demir, C. (2022). Role of Oxidative stress in Obese and Non-obese PCOS Patients. Int J of Clin Pract. https://doi.org/10.1155/2022/4579831
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M. & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology, 39(1), 44–84. https://doi.org/10.1016/j.biocel.2006.07.001.
Zhang D., Luo W.-Y., Liao H., Wang C. F. & Sun Y. (2008). The effects of oxidative stress to PCOS. Sichuan da xue xue bao. Yi xue ban, Journal of Sichuan University. Medical science edition, 39(3), 421–423.
Zhang, J.; Bao, Y.; Zhou, X. & Zheng, L. (2019) Polycystic ovary syndrome and mitochondrial dysfunction. Reprod. Biol. Endocrinol.17, 1–15 https://doi.org/10.1186%2Fs12958-019-0509-4
Zuo, T., Zhu, M. & Xu, W. (2016). Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxidative Medicine and Cellular Longevity, 2016, 8589318. https://doi.org/10.1155/2016/8589318.